Nobuaki Ochi

2.2k total citations
127 papers, 1.4k citations indexed

About

Nobuaki Ochi is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Nuclear and High Energy Physics. According to data from OpenAlex, Nobuaki Ochi has authored 127 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Pulmonary and Respiratory Medicine, 58 papers in Oncology and 26 papers in Nuclear and High Energy Physics. Recurrent topics in Nobuaki Ochi's work include Lung Cancer Treatments and Mutations (43 papers), Astrophysics and Cosmic Phenomena (26 papers) and Lung Cancer Research Studies (21 papers). Nobuaki Ochi is often cited by papers focused on Lung Cancer Treatments and Mutations (43 papers), Astrophysics and Cosmic Phenomena (26 papers) and Lung Cancer Research Studies (21 papers). Nobuaki Ochi collaborates with scholars based in Japan, United States and Bolivia. Nobuaki Ochi's co-authors include Nagio Takigawa, Katsuyuki Kiura, Eiki Ichihara, Mitsune Tanimoto, Katsuyuki Hotta, Soji Tsuchiya, Hiromichi Yamane, Daijiro Harada, Takashi Ninomiya and Masahiro Tabata and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Nobuaki Ochi

120 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nobuaki Ochi Japan 21 820 585 430 142 106 127 1.4k
Alfred Morgenstern Germany 32 548 0.7× 996 1.7× 339 0.8× 166 1.2× 82 0.8× 103 2.9k
Jingsheng Yan United States 26 431 0.5× 635 1.1× 444 1.0× 90 0.6× 282 2.7× 71 1.9k
Robert W. Atcher United States 26 455 0.6× 619 1.1× 360 0.8× 168 1.2× 118 1.1× 64 2.2k
Franck Morin France 24 921 1.1× 1.2k 2.0× 465 1.1× 116 0.8× 299 2.8× 145 2.2k
F. Recchia Italy 19 549 0.7× 208 0.4× 236 0.5× 79 0.6× 138 1.3× 118 1.3k
Kazuki Sakamoto Japan 17 580 0.7× 196 0.3× 307 0.7× 43 0.3× 78 0.7× 96 1.4k
Dipankar Ray United States 25 548 0.7× 234 0.4× 1000 2.3× 59 0.4× 197 1.9× 102 1.7k
Yasuyuki Sugiyama Japan 24 551 0.7× 415 0.7× 678 1.6× 93 0.7× 322 3.0× 170 2.1k
Franco Perrone Italy 20 483 0.6× 291 0.5× 121 0.3× 134 0.9× 180 1.7× 71 1.2k
Matthew S. Block United States 27 992 1.2× 224 0.4× 563 1.3× 187 1.3× 171 1.6× 142 2.3k

Countries citing papers authored by Nobuaki Ochi

Since Specialization
Citations

This map shows the geographic impact of Nobuaki Ochi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuaki Ochi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuaki Ochi more than expected).

Fields of papers citing papers by Nobuaki Ochi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuaki Ochi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuaki Ochi. The network helps show where Nobuaki Ochi may publish in the future.

Co-authorship network of co-authors of Nobuaki Ochi

This figure shows the co-authorship network connecting the top 25 collaborators of Nobuaki Ochi. A scholar is included among the top collaborators of Nobuaki Ochi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nobuaki Ochi. Nobuaki Ochi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Morita, Ayako, Eiki Ichihara, Koji Inoue, et al.. (2024). Impacts of probiotics on the efficacies of immune checkpoint inhibitors with or without chemotherapy for patients with advanced non‐small‐cell lung cancer. International Journal of Cancer. 154(9). 1607–1615. 14 indexed citations
3.
Sunada, Yoshihide, et al.. (2024). A case of primary duodenal Brunner's gland hamartoma that gradually underwent morphological changes over a period of 10 years. SHILAP Revista de lepidopterología. 5(1). e70028–e70028. 1 indexed citations
4.
Yamane, Hiromichi, et al.. (2023). Clinical Features of Patients With Hematological Malignancies Treated at the Palliative Care Unit. SHILAP Revista de lepidopterología. 4(1). 278–287. 3 indexed citations
5.
Kubo, Toshio, Eiki Ichihara, Daijiro Harada, et al.. (2023). Efficacy of immune checkpoint inhibitor monotherapy in elderly patients with non-small-cell lung cancer. Respiratory Investigation. 61(5). 643–650. 3 indexed citations
6.
Ichihara, Eiki, Toshihide Yokoyama, Koji Inoue, et al.. (2022). The Effect of Pleural Effusion on Prognosis in Patients with Non-Small Cell Lung Cancer Undergoing Immunochemotherapy: A Retrospective Observational Study. Cancers. 14(24). 6184–6184. 4 indexed citations
7.
Miyake, Noriko, Nobuaki Ochi, Hiromichi Yamane, et al.. (2021). Targeting ROR1 in combination with osimertinib in EGFR mutant lung cancer cells. Experimental Cell Research. 409(2). 112940–112940. 4 indexed citations
8.
Hara, Naofumi, Eiki Ichihara, Daijiro Harada, et al.. (2021). Significance of PD-L1 expression in the cytological samples of non-small cell lung cancer patients treated with immune checkpoint inhibitors. Journal of Cancer Research and Clinical Oncology. 147(12). 3749–3755. 7 indexed citations
9.
Ochi, Nobuaki, Eiki Ichihara, Nagio Takigawa, et al.. (2021). The effects of antibiotics on the efficacy of immune checkpoint inhibitors in patients with non–small-cell lung cancer differ based on PD-L1 expression. European Journal of Cancer. 149. 73–81. 43 indexed citations
10.
Ichihara, Eiki, Daijiro Harada, Koji Inoue, et al.. (2020). Characteristics of patients with EGFR-mutant non-small-cell lung cancer who benefited from immune checkpoint inhibitors. Cancer Immunology Immunotherapy. 70(1). 101–106. 28 indexed citations
11.
Kano, Hirohisa, Eiki Ichihara, Daijiro Harada, et al.. (2020). Utility of immune checkpoint inhibitors in non‐small‐cell lung cancer patients with poor performance status. Cancer Science. 111(10). 3739–3746. 18 indexed citations
12.
Ichihara, Eiki, Daijiro Harada, Koji Inoue, et al.. (2019). The impact of body mass index on the efficacy of anti-PD-1/PD-L1 antibodies in patients with non-small cell lung cancer. Lung Cancer. 139. 140–145. 74 indexed citations
13.
Isozaki, Hideko, Eiki Ichihara, Nagio Takigawa, et al.. (2016). Non–Small Cell Lung Cancer Cells Acquire Resistance to the ALK Inhibitor Alectinib by Activating Alternative Receptor Tyrosine Kinases. Cancer Research. 76(6). 1506–1516. 109 indexed citations
14.
Yamane, Hiromichi, Hideko Isozaki, Masami Takeyama, et al.. (2015). Programmed cell death protein 1 and programmed death-ligand 1 are expressed on the surface of some small-cell lung cancer lines.. Europe PMC (PubMed Central). 5(4). 1553–7. 27 indexed citations
15.
Yamane, Hiromichi, et al.. (2013). Fatal interstitial pneumonia caused by panitumumab-containing chemotherapy: a case report. 39(1). 49–53. 2 indexed citations
16.
Ninomiya, Takashi, Nagio Takigawa, Eiki Ichihara, et al.. (2013). Afatinib Prolongs Survival Compared with Gefitinib in an Epidermal Growth Factor Receptor-Driven Lung Cancer Model. Molecular Cancer Therapeutics. 12(5). 589–597. 54 indexed citations
17.
Minami, Daisuke, Nagio Takigawa, Minoru Takata, et al.. (2012). Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN -Deficient Lung Cancer Cells. Molecular Cancer Research. 11(2). 140–148. 50 indexed citations
18.
Iyono, A., T. Wada, S. Ôhara, et al.. (2008). Zenith Angle Distribution and Atmospheric Effect for EAS with LAAS experiments. International Cosmic Ray Conference. 4. 47–50. 1 indexed citations
19.
Katayama, T., N. Kawakami, T. Nakatsuka, et al.. (2001). Atmospheric muon measurements I: Vertical measurements. ICRC. 3. 931. 1 indexed citations
20.
Takahashi, Chiharu, et al.. (1998). Moisture Measurement in Air by Vacuum Ultraviolet Light-Excited Fluorescence Method. 47(4). 369–374. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alfred Morgenstern Breakdown of academic impact, for papers by Jingsheng Yan Breakdown of academic impact, for papers by Robert W. Atcher Breakdown of academic impact, for papers by Franck Morin Breakdown of academic impact, for papers by F. Recchia Breakdown of academic impact, for papers by Kazuki Sakamoto Breakdown of academic impact, for papers by Dipankar Ray Breakdown of academic impact, for papers by Yasuyuki Sugiyama Breakdown of academic impact, for papers by Franco Perrone Breakdown of academic impact, for papers by Matthew S. Block
Rankless by CCL
2026